Pharmacokinetics and Safety Study of Apetrol ES

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2010

Conditions
Healthy
Interventions
DRUG

Apetrol ES / Megace

Sequences of administered drugs

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Severance Hospital

OTHER

lead

LG Life Sciences

INDUSTRY

NCT02446353 - Pharmacokinetics and Safety Study of Apetrol ES | Biotech Hunter | Biotech Hunter